Prevalence of poor sleep quality in COVID-19 patients: a systematic review and meta-analysis

Zhen Gui, Yue-Ying Wang, Jiaxin Li, Tao Xiang2023 · DOI

Introduction

While COVID-19 is primarily recognized as a respiratory illness, its long-term impact involves significant neurological and psychological morbidity. Among these, sleep disruption—often colloquially termed "coronasomnia"—has emerged as a major concern for survivors. Sleep is a fundamental pillar of immune function and mental health, yet existing reports on poor sleep quality (PSQ) among COVID-19 patients remain fragmented across localized studies.

This paper outlines a rigorous protocol for a systematic review and meta-analysis designed to synthesize global data. By moving beyond anecdotal evidence, the study aims to determine the precise prevalence of PSQ among survivors and identify whether specific clinical milestones, such as ICU admission or hospital discharge, act as triggers for sleep disturbances.

Objectives and Scope

The primary objective of this study is to quantify the prevalence of poor sleep quality in COVID-19 patients across all stages of the disease, including acute infection, symptom onset, recovery, and the post-acute phase. The research follows the PICOS framework:

  • Participants (P): Individuals with confirmed COVID-19 (via RT-PCR or clinical history).
  • Interventions (I): Not applicable.
  • Comparisons (C): Healthy controls (where available in comparative studies).
  • Outcome (O): Prevalence of PSQ, specifically as measured by standardized tools such as the Pittsburgh Sleep Quality Index (PSQI).
  • Study Design (S): Epidemiological and comparative studies.

Methodology

The study adheres to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) and MOOSE guidelines to ensure transparency and reproducibility.

Search Strategy and Data Extraction

Researchers will conduct a systematic sweep of four major databases: PubMed, Web of Science, Embase, and PsycINFO. The search strategy utilizes a complex string of MeSH terms and keywords related to COVID-19 and sleep architecture. To maintain data purity, the study will exclude patients with pre-existing sleep disorders, ensuring that the results specifically reflect the impact of the viral infection.

Statistical Analysis

A random-effects model will be employed to estimate pooled prevalence. To account for the inherent variability in global data, the $I^2$ statistic will be used to measure heterogeneity. Furthermore, the quality of evidence will be graded using an eight-item instrument for epidemiological studies and the Newcastle-Ottawa Scale (NOS) for comparative studies.

Key Analytical Features

One of the most significant aspects of this protocol is the planned subgroup and meta-regression analyses:

  • Socioeconomic Dimension: The researchers intend to categorize data based on World Bank income levels. This will help identify if sleep disorder prevalence varies between high-income and lower-middle-income countries, potentially highlighting global health inequities.
  • Temporal Tracking: Data will be categorized based on time elapsed since symptom onset or hospital discharge. This temporal approach will reveal whether sleep quality improves or deteriorates as patients move further away from the acute phase of the illness.
  • Clinical Predictors: Meta-regression will be used to identify which continuous variables, such as mean age or duration of hospitalization, most strongly predict sleep issues.

Expected Outcomes and Significance

As this is a protocol registration, final results are currently pending. However, the intended outputs include the pooled prevalence of PSQ and Odds Ratios (OR) comparing COVID-19 patients to healthy controls.

While the study is limited by its restriction to English-language articles and its dependence on the consistency of primary study reporting, it will provide a vital benchmark. Once completed, this synthesis will assist clinicians in developing integrated sleep hygiene interventions as part of post-acute COVID-19 (Long COVID) treatment protocols.

Summary updated

Abstract

Review question / Objective: The inclusion criteria for this study are based on the PICOS acronym: Participants (P): COVID-19 patients based on positive Coronavirus RT-PCR (reverse transcription-polymerase chain reaction) of nasopharyngeal and oropharyngeal swabs or a history of COVID-19 infection. Following previous research, the COVID-19 patients in this study will include the period of COVID-19 infection, symptom onset, recovery, and the onset of post-acute COVID-19 symptoms. Interventions (I): not applicable; Comparisons (C): healthy controls in comparative studies, or not applicable to epidemiological surveys; Outcome (O): the prevalence of poor sleep quality (PSQ) or available data could yield the prevalence of PSQ in COVID-19 patients. Sleep quality in COVID-19 patients will be assessed using standardized scales such as the Pittsburgh Sleep Quality Index (PSQI); Study design (S): epidemiological and comparative studies (only the baseline data of cohort study will be extracted).
BibTeX
@misc{gui2023prevalence,
  author = {Zhen Gui and Yue-Ying WANG and Jiaxin Li and Tao Xiang},
  title = {{Prevalence of poor sleep quality in COVID-19 patients: a systematic review and meta-analysis}},
  year = {2023},
  doi = {10.37766/inplasy2023.2.0121},
}
Figure